Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for optic nerve disease.

K R G Martin1, H A Quigley

  • 1Eye Department, Addenbrookes Hospital, Cambridge, UK. kmartin1@doctors.org.uk

Eye (London, England)
|November 10, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selective loss of pattern discrimination in early glaucoma.

Applied optics·2010
Same author

Effect of cataract on a scotopic sensitivity screening test for glaucoma.

Journal of glaucoma·2009
Same author

The number of people with glaucoma worldwide in 2010 and 2020.

The British journal of ophthalmology·2006
Same author

Parafoveal retinal telangiectasis: light and electron microscopy studies. 1977.

Retina (Philadelphia, Pa.)·2005
Same author

New paradigms in the mechanisms and management of glaucoma.

Eye (London, England)·2004
Same author

Stem cells to replace the optic nerve.

Eye (London, England)·2004
Same journal

Tubing the trabeculectomy: a novel filtration technique.

Eye (London, England)·2026
Same journal

Retinal non-perfusion progression in severe non-proliferative and proliferative diabetic retinopathy over time: INSPIRED study report 2.

Eye (London, England)·2026
Same journal

Macular serpiginous choroiditis versus macular serpiginous-like choroiditis: clinical features, outcomes and prognosis.

Eye (London, England)·2026
Same journal

Association of baseline brain care score with the incidence of age-related eye diseases.

Eye (London, England)·2026
Same journal

A comparative analysis of carbon dioxide versus nitrous oxide as the pressurised gas driving a retinal cryotherapy unit.

Eye (London, England)·2026
Same journal

Determinants of regression kinetics in observed stage 3 retinopathy of prematurity without plus disease.

Eye (London, England)·2026
See all related articles

Gene therapy shows promise for optic nerve diseases like Leber

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Genetics

Background:

  • Gene therapy is emerging as a potential treatment for ocular diseases.
  • Optic nerve conditions are increasingly being explored for gene therapy applications.

Purpose of the Study:

  • To identify optic nerve diseases most suitable for gene therapy.
  • To review gene transfer successes in animal models and assess future human applications.

Main Methods:

  • Review of gene transfer experiments in animal models.
  • Assessment of adeno-associated virus (AAV) for retinal ganglion cell transfection.
  • Evaluation of gene therapy for Leber's hereditary optic neuropathy (LHON).

Main Results:

  • Successful AAV-mediated gene therapy demonstrated neuroprotection in a rat glaucoma model.

Related Experiment Videos

  • AAV successfully replaced defective mitochondrial enzyme subunits in LHON patient-derived cells.
  • Gene therapy showed promise in animal models for optic neuritis and optic nerve trauma.

    • Conclusions:

    • Single-gene defect diseases like LHON may soon be treatable with gene therapy.
    • Gene therapy could enhance retinal ganglion cell survival in conditions like glaucoma.
    • Balancing treatment risks and benefits is crucial for all gene therapy applications.